Showing results (411-420 of 650) with videos related to
Sort By:
Pageof 65
Nature Cancer|March 27, 2023
Apoptosis-induced nuclear expulsion in tumor cells drives S100a4-mediated metastatic outgrowth through the RAGE pathwayWoo-Yong Park, Justin M Gray, Ronald J Holewinski, et al.Nature Cancer|November 7, 2022
MACHETE identifies interferon-encompassing chromosome 9p21.3 deletions as mediators of immune evasion and metastasisFrancisco M Barriga, Kaloyan M Tsanov, Yu-Jui Ho, et al.Nature Cancer|March 9, 2023
CD4+ T cells in cancerDaniel E Speiser, Obinna Chijioke, Karin Schaeuble, et al.Nature Cancer|February 22, 2023
Advances in antibody-based therapy in oncologySacha Zinn, Rodrigo Vazquez-Lombardi, Carsten Zimmermann, et al.Nature Cancer|February 9, 2023
A reversible SRC-relayed COX2 inflammatory program drives resistance to BRAF and EGFR inhibition in BRAFV600E colorectal tumorsAna Ruiz-Saenz, Chloe E Atreya, Changjun Wang, et al.Nature Cancer|March 7, 2025
Hallmarks of artificial intelligence contributions to precision oncologyTian-Gen Chang, Seongyong Park, Alejandro A Schäffer, et al.Nature Cancer|January 21, 2025
Targeting BRCA1-deficient PARP inhibitor-resistant cells with nickases reveals nick resection as a cancer vulnerabilityJenna M Whalen, Jillian Earley, Christi Wisniewski, et al.Nature Cancer|March 18, 2025
Odronextamab monotherapy in patients with relapsed/refractory diffuse large B cell lymphoma: primary efficacy and safety analysis in phase 2 ELM-2 trialWon Seog Kim, Tae Min Kim, Seok-Goo Cho, et al.Nature Cancer|October 22, 2024
Selenocysteine tRNA methylation promotes oxidative stress resistance in melanoma metastasisLeona A Nease, Kellsey P Church, Ines Delclaux, et al.Nature Cancer|October 11, 2024
The neuroendocrine transition in prostate cancer is dynamic and dependent on ASCL1Rodrigo Romero, Tinyi Chu, Tania J González Robles, et al.Pageof 65